ByrneWallace

Life Sciences Department

Ireland
Current View:

This content is provided by ByrneWallace.

Overview

Ranked as a top tier practice group, our dedicated Life Sciences team is led by Colin Sainsbury, who previously held senior in-house legal positions in the pharmaceutical and biotech industry and has extensive sectoral specific international commercial and regulatory experience.

Our team draws on the specialist skills and technical expertise of lawyers from a range of practice areas including corporate, capital markets, regulatory, intellectual property, healthcare and health services, employment, litigation, tax, product liability, EU and competition, property, projects and construction teams, as well as other specialist practice areas.

We advise all types of enterprises active in the life sciences industry. Our clients range from the earliest stage university spin-out companies to established publicly quoted indigenous companies and global pharmaceutical, biotech and medical device organisations. The team regularly acts in a broad range of cutting edge transactions ranging from M&A and financing deals to strategic transactions. We also act for venture capital and private equity funds investing in the Irish life sciences industry, research institutions and companies involved in the establishment and provision of healthcare services.

Our specialist skill sets, together with real industry and regulatory experience and a dedicated approach to serving the life sciences industry, enables us to provide the highest quality legal service in a focused manner.

Industries

Bio Tech

Life Sciences

Med Tech

Medical Devices

Pharmaceuticals